PUBLICATIONS
|
Chronic Inflammation / Immunopharmacology (1989-2008) |
- Reviews / Invited Contributions / Book Chapters
| Parathyroid Hormone / Calcium Metabolism (1983-1990) |
- Reviews / Invited Contributions / Book Chapters
______________________________________________________________________________________________________________
Chronic Inflammation / Immunopharmacology (1989-2008)
98. Alban S; Ludwig RJ; Bendas G; Schön MP; Oostingh G; Radeke HH; Fritzsche J; Pfeilschifter JM; Kaufmann R; Boehncke WH. PS3, a semisynthetic ß1-3 glucan-sulfate, diminishes contact hypersensitivity responses through inhibition of L- and P-selectin functions. Journal of Investigative Dermatology , advance online publication, 4 December 2008; doi:10.1038/jid.2008.358; 2008
97. Giegold O; Ludwig RJ; Hardt K; Will J; Schön MP; Oostingh GJ; Pfeilschifter JM; Boehncke WH; Radeke HH. Computer-aided analysis of cell-interactions under dynamic flow conditions. Experimental Dermatology, published online, 2008
96. Wiesemann E; Deb M; Hemmer B; Radeke HH; Windhagen A. Early identification of interferon-beta responders by ex vivo testing in patients with multiple sclerosis. Clinical Immunology, 128(3):306-313, 2008
95. Schramme A; Abdel-Bakky MS; Obermüller N; Baer PC; Hauser IA; Ludwig A; Gauer S; Schäfer L; Sobkowiak E; Altevogt P; K oziolek M; Kiss E; Gröne HJ; Tikkanen R; Goren I; Radeke HH ; Pfeilschifter JM; Gutwein P. Characterization of CXCL16 and ADAM10 in the normal and transplanted human kidney. Kidney International, 74(3):328-338, 2008
94. Doller A; Akool ES; Huwiler A; Müller R; Radeke HH; Pfeilschifter JM; Eberhardt W. Posttranslational modification of the AU-rich element binding protein HuR by PKC elicits angiotensin II-induced stabilization and nuclear export of COX-II mRNA. Molecular and Cellular Biology, 28(8):2608-25, 2008
93. Daniel C; Sartory NA; Zahn N; Radeke HH*; Stein J*. Immune modulatory treatment of TNBS colitis with calcitriol is associated with a change of a Th1/Th17 to a Th2 and regulatory T cell profile. Journal of Pharmacology and Experimental Therapeutics, 324(1):23-33, 2008 [* both authors contributed equally] (PDF)
92. Daniel C; Sartory N; Zahn N; Schmidt R; Geisslinger G; Radeke HH*; Stein J*. FTY720 directly affects T helper type 2 effector functions via the IL-1 receptor-related protein T1/ST2 to ameliorate oxazolone-colitis in mice. Molecular Immunology , 44(13):3305-3316, 2007 [* both authors contributed equally] (PDF)
91. Behrens F; Himsel A; Rehart S; Stanczyk J; Beutel B; Zimmermann SY; Köhl U; Moeller B; Gay S; Kaltwasser JP; Pfeilschifter JM; Radeke HH. Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis. Annals of the Rheumatic Diseases, 66:1151-1156, 2007 (PDF)
90. Doller A; Huwiler A; Müller R; Radeke HH; Pfeilschifter JM; Eberhardt W. Regulation of nucleo-cytoplasmic shuttling of the mRNA stabilizing factor HuR by PKCa . Molecular Biology of the Cell, 18(6):2137-2148, 2007 (PDF)
89. Daniel C; Sartory N; Zahn N; Geisslinger G; Radeke HH*; Stein J*. FTY 720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD 25+ regulatory T cells. Journal of Immunology, 178(4):2458-2468, 2007 [* both authors contributed equally] (PDF)
88. Keller C; Rivera Gi P; Tölle M; van der Giet M; Chun J; Radeke HH; Schäfer-Korting M; Kleuser B. Immunmodulator FTY 720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signalling. American Journal of Pathology, 170:281-292, 2007 (PDF)
87. Ramos-Lopez E; Brück P; Jansen T; Pfeilschifter JM; Radeke HH; Badenhoop K. CYP2R1-, CYP27B1- and CYP24-mRNA expression in German type 1 diabetes patients. Journal of Steroid Biochemistry and Molecular Biology, 103(3-5):807-10, 2007
86 . Waibler Z; Kalinke U; Will J; Herrero San Juan M; Pfeilschifter JM; Radeke HH. TLR-ligand stimulated interleukin- 23 subunit expression and assembly is regulated differentially in murine plasmacytoid and myeloid dendritic cells. Molecular Immunology, 44(7):1483-1489, 2007 (PDF)
85. Daniel C; Radeke HH; Sartory NA; Zuegel U; Steinmeyer A; Stein J. The new low calcemic vitamin D analogue 22-ene-25-oxa-vitamin D ameliorates Th1-mediated colitis in mice. Journal of Pharmacology and Experimental Therapeutics , 319(2):622-631, 2006 (PDF)
84. Beck S; Beck G; Ostendorf T; Floege J; Lambeau G; Nevalainen T; Radeke HH; Gurrieri S; Haas U; Thorwart B; Pfeilschifter JM; Kaszkin M. Upregulation of group IB secreted phospholipase A2 and its M-type receptor in rat ANTI-THY-1 glomerulonephritis. Kidney International 70(7):1251-1260, 2006
83. Rubant S; Schwarz M; Werner E; Luttmann R; Ludwig RJ; Boehncke WH; Pfeilschifter JM; Radeke HH. Eukaryotic expression of the broad-spectrum chemokine receptor antagonist vMIP-II and its effects on T cell function in vitro and in vivo. Experimental Dermatology 15(8):634-642, 2006 (PDF)
82. Ludwig RJ; Zollner TM; Santoso S; Hardt K; Gille J; Baatz H; Schulze-Johann P; Pfeffer J; Radeke HH; Schön MP; Kaufmann R; Boehncke WH; Podda M. Junctional Adhesion Molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation. Journal of Investigative Dermatology 125 (5):969-976, 2005 (PDF)
81. Daniel C; Schlauch T; Zugel U; Steinmeyer A; Radeke HH; Steinhilber D; Stein J. 22-ene- 25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities. European Journal of Clinical Investigation 35(5):343-349, 2005 (PDF)
80. Hauser IA; Spiegler S; Kiss E; Gauer S; Sichler O; Scheuermann EH; Ackermann H; Pfeilschifter JM; Geiger H; Gröne H-J; Radeke HH. Prediction of acute renal allograft rejection by urinary monokine induced by IFN- g (MIG). Journal of the American Society of Nephrology, 16(6):1849-1858, 2005 (PDF)
79. Radeke HH; von Wenckstern H; Stoidtner K; Schraut C; Kleuser B. Overlapping signaling pathways of sphingosine 1-phosphate and transforming growth factor-ß in murine Langerhans cells. Journal of Immunology 174:2778-2786, 2005 (PDF)
78. Kautz K; Schwarz M; Radeke HH. Interference with MCP-1 gene expression by vector generated triple helix-forming RNA oligonucleotides. Cellular and Molecular Life Sciences 62:362-376, 2005 (PDF)
77. Xin C; Ren S; Kleuser B; Schäfer-Korting M; Shabahang S; Eberhardt W; Radeke HH; Pfeilschifter JM; Huwiler A. Sphingosine-1-phosphate cross-activates the Smad signaling cascade and mimics TGFß-induced cell responses in renal mesangial cells. Journal of Biological Chemistry 279(34):35255-35262, 2004 (PDF)
76. Cornelissen G; Bertelsen H-P; Hahn B, Schultz M; Scheffler U; Werner E; Leptien H; Krüß S; Jansen A-K; Gliem T; Hielscher M; Wilhelm B-U; Sowa E; Radeke HH; Luttmann R. Herstellung rekombinanter Proteine mit Pichia pastoris in integrierter Prozessführung. Chemie Ingenieur Technik, 75(3):281-290, 2003
75. Janssen U; Sowa E; Marchand P;
Floege J; Phillips AO; Radeke HH. Differential Expression of MCP-1 and
its receptor CCR2 in glucose primed human mesangial cells. Nephron, 92:797-806,
2002 [PDF]
74. Radeke HH;
Janssen-Graalfs I; Sowa EN; Löscher F; Schmidt RE; Gessner JE. Opposite
regulation of type II and II receptors for immunoglobulin G in mouse glomerular
mesangial cells. Journal of Biological Chemistry 277:27535-27544, 2002 [PDF]
73. Schwarz M; Wahl
M; Resch K; Radeke HH. IFN-gamma induces functional chemokine receptor expression
and responsiveness in human mesangial cells. Clinical and Experimental Immunology
128:285-294, 2002 [PDF]
72. Radeke HH;
Tschernig T; Karulin A; Schumm G; Emancipator SN; Resch K; Tary-Lehmann M. CD4+
T cells recognizing specific antigen deposited in glomeruli cause glomerulonephritis-like
kidney injury. Clinical Immunology 104(2):161-173, 2002 [PDF]
71.
Martin U; Winkler ME; Id M; Radecke HH;
Arseniev L; Grotelüschen R; Simon AR;
Steinhoff G. Transmission
of Pig Endogenous Retrovirus (PERV) to Primary Human Cells.
Transplantation
Proceedings,
2000,
32(5):1157-1157
70. Marchand P; Resch K; Radeke
HH. Selective Inhibition of monocyte chemoattractant protein-1 (MCP-1) gene
transcription in embryonic kidney cells by specific triple helix-forming oligonucleotides.
Journal of Immunology, 2000, 164:2070-2076 [PDF]
69. Mühl H; Kämpfer H; Bosmann M; Frank S;
Radeke HH; Pfeilschifter J. Interferon-gamma mediates gene expression
of IL-18 binding protein in nonleukocytic cells. Biochemical and Biophysical
Research Communications, 2000, 267:960-963
68.
Martin U; Winkler ME; Id M; Radeke HH;
Arseniev L; Takeuchi Y; Simon AR; Patience C; Haverich A; Steinhoff G. Productive
Infection of Primary Human Endothelial Cells by Pig Endogenous Retrovirus (PERV).
Xenotransplantation
2000, 7(2):138-142
67. Yip HC; Karulin A; Tary-Lehmann M; Hesse MD; Radeke HH; Heeger PS; Trezza RP; Heinzel FP; Forsthuber T; Lehmann PV. Adjuvant guided Th1 or Th2 immunity: infectious / noninfectious dichotomy defines the class of response. Journal of Immunology, 1999, 162:3942-3949.
66. Hauser IA; Renders L; Radeke HH; Sterzel RB; Goppelt-Struebe M. Mycophenolate mofetil (MMF) inhibits rat and human mesangial cell proliferation by guanosin depletion. Nephrology, Dialysis and Transplantation, 1999, 14:58-63.
65. Ostendorf T; Janssen U; Burg M; Radeke HH; Janjic N; Floege J. A novel approach to specific growth factor inhibition in vivo: Antagonism of PDGF in experimental mesangioproliferative glomerulonephritis by DNA ligands. American Journal of Pathology, 1999, 154:169-179
64. Uciechowski P; Schwarz M; Gessner JE; Schmidt RE; Resch K; Radeke HH. Interferon-g induces the high affinity Fc-receptor for IgG (CD64) on human glomerular mesangial cells. European Journal of Immunology, 1998, 28:2928-2935.
63. Schwarz M; Radeke HH; Resch K; Uciechowski P. Lymphocyte-derived cytokines induce sequential expression of monocyte- and T cell-specific chemokines in human mesangial cells. Kidney International, 1997, 52:1521-1531.
62. D´Souza RJ; Phillips HM; Radeke HH; Aber GM; Strange RC. Mesangial cell DNA synthesis induced by hydrogen peroxide, interleukin-6, and platelet-derived growth factor: effects of indomethacin and dazmegrel. Nephron, 1996, 72:263-268.
61. Gessner JE; Radeke HH; Uciechowski P; Resch K; Schmidt RE. Activation dependent expression of Fc gamma-receptors on glomerular mesangial cells. Immunität und Infektion, 1995, 23:67-69.
60. Francki A; Uciechowski P; Floege J; von der Ohe J; Resch K; Radeke HH. Autocrine growth regulation of human glomerular mesangial cells is primarily mediated by basic fibroblast growth factor. American Journal of Pathology, 1995, 147:1372-1382
59. Radeke HH; Gessner JE; Uciechowski P; Magert HJ; Schmidt RE; Resch K. Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chain. Journal of Immunology, 1994, 153:1281-1292.
58. Radeke HH; Emmendorffer A; Uciechowski P; von der Ohe J; Schwinzer B; Resch K. Activation of autoreactive T-lymphocytes by cultured syngeneic glomerular mesangial cells. Kidney International, 1994, 45:763-774.
57. Radeke HH; Kuster S; Kaever V; Resch K. Effects of cyclosporin and FK-506 on glomerular mesangial cells. Evidence for direct inhibition of thromboxane synthase by low cyclosporin concentrations. European Journal of Clinical Pharmacology, 1993, 44:S11-S16.
56. Radeke HH; Schwinzer B; Resch K. Activated T-lymphocytes induce growth inhibition and prostaglandin E2 release from syngeneic glomerular mesangial cells. Clinical and Experimental Immunology, 1992, 90:483-490.
55. Radeke HH; Christians U; Sewing KF; Resch K. The synergistic immunosuppressive potential of cyclosporin metabolite combinations. International Journal of Immunopharmacology, 1992, 14(4):595-604.
54. Christians U; Sattler M; Schiebel HM; Kruse C; Radeke HH; Linck A; Sewing KF. Isolation of two immunosuppressive metabolites after in vitro metabolism of rapamycin. Drug Metabolism and Disposition, 1992, 20(2):186-191.
53. Steiner P; Pfeilschifter J; Boeckh C; Radeke H; Otten U. Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor synthesis in rat mesangial cells. American Journal of Physiology, 1991, 261:F792-F798.
52. Radeke HH; Cross AR; Hancock JT; Jones OT; Nakamura M; Kaever V; Resch K. Functional expression of NADPH oxidase components (alpha- and beta-subunits of cytochrome b558 and 45-kDa flavoprotein) by intrinsic human glomerular mesangial cells. Journal of Biological Chemistry, 1991, 266:21025-21029 (PDF)
51. Radeke HH; Christians U; Bleck JS; Sewing KF; Resch K. Additive and synergistic effects of cyclosporine metabolites on glomerular mesangial cells. Kidney International, 1991, 39:1255-1266.
50. Radeke HH; Martin M; Topley N; Kaever V; Resch K. Differential biological activities of human interleukin-1 alpha and interleukin-1 beta. European Cytokine Network, 1991, 2:51-59.
49. Kaever V; Wessel K; Radeke HH; Resch K. Influence of the intracellular free calcium level and calmodulin antagonists on prostaglandin and leukotriene synthesis in murine macrophages. Agents and Actions, 1991, 32:82-84.
48. Radeke HH; Schwinzer B; von der Ohe J; Bovenkerk C; Resch K. Modulation of glomerular mesangial cell growth and prostaglandin release by T-lymphocyte products. Agents and Actions, 1991, 32:109-111.
47. Christians U; Radeke HH; Kownatzki R; Schiebel HM; Schottmann R; Sewing KF. Isolation of an immunosuppressive metabolite of FK506 generated by human microsome preparations. Clinical Biochemistry, 1991, 24:271-275.
46. Sewing KF; Christians U; Kohlhaw K; Radeke H; Strohmeyer S; Kownatzki R; Budniak J; Schottmann R; Bleck JS; Almeida VMF; Deters M; Wonigeit K; Pichlmayr R. Biologic activity of cyclosporine metabolites. Transplantation Proceedings, 1990, 22:1129-1134.
45. Floege J; Topley N; Wessel K; Kaever V; Radeke H; Hoppe J; Kishimoto T; Resch K. Monokines and platelet-derived growth factor modulate prostanoid production in growth arrested, human mesangial cells. Kidney International, 1990, 37:859-869.
44. Radeke HH; Meier B; Topley N; Floge J; Habermehl GG; Resch K. Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney International, 1990, 37:767-775.
43. Meier B; Radeke HH; Selle S; Habermehl GG; Resch K; Sies H. Human fibroblasts release low amounts of reactive oxygen species in response to the potent phagocyte stimulants, serum-treated zymosan, N-formyl-methionyl-leucyl-phenylalanine, leukotriene B4 or 12-O-tetradecanoylphorbol 13-acetate. Biological Chemistry Hoppe-Seyler, 1990, 371:1021-1025.
42. Kaever V; Bruuns J; Wunder J; Damerau B; Zimmer G; Fauler J; Wessel K; Floege J; Topley N; Radeke HH; Resch K. Human glomerular mesangial cells inactivate leukotriene B4 by reduction into dihydro-leukotriene B4 metabolites. Life Sciences, 1990, 46:1465-1470.
41. Meier B; Radeke HH; Selle S; Raspe HH; Sies H; Resch K; Habermehl GG. Human fibroblasts release reactive oxygen species in response to treatment with synovial fluids from patients suffering from arthritis. Free Radical Research Communications, 1990, 8:149-160.
40. Meier B; Radeke HH; Selle S; Raspe HH; Sies H; Resch K; Habermehl GG. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-a. Biochemical Journal, 1989, 263:539-545.
39. Topley N; Floege J; Wessel K; Hass R; Radeke HH; Kaever K; Resch K. Prostaglandin E2 production is synergistically increased in cultured human glomerular mesangial cells by combinations of IL-1 and tumor necrosis factor-a. Journal of Immunology, 1989, 143:1989-1995.
______________________________________________________________________________________________________________
Reviews / Invited Contributions / Book Chapters
38. Radeke HH; Ludwig RJ; Boehncke WH. Experimental Approaches to Lymphocyte Migration in Dermatology in vitro and in vivo. Experimental Dermatology, in press, 2005
37. Calderwood JW; Radeke HH. Chapter 4: In-vitro techniques to investigate lymphocyte extravasation. In: "Lymphocyte homing to the skin" Boehncke WH (Ed.), CRC Press, Boca Raton, FL, USA, in press, 2005
36. Cornelissen G; Leptien H; Pump D; Scheffler U; Sowa E; Radeke HH; Luttmann R. Integrated bioprocess development for production of recombinant proteins in high cell density cultivation with Pichia Pastoris. Computer Applications in Biotechnology (CAB), 8 :1-6, 2001 (PDF)
35. Schwarz M; Radeke HH. Chemokines and Inflammatory Renal Diseases. Kidney and Blood Pressure Research, 2001, 24:409-411 [PDF]
34. Resch K; Radeke
HH. Teil 1 Grundlagen, Kap. "Entzündung" in "Interdisziplinäre
Klinische Rheumatologie. Innere Medizin-Orthopädie-Immunologie". Zeidler
H, Zacher J, Hiepe F (Hrsg.), Springer Verlag Berlin-New York-Tokio, 2001, pp
41-63
33. Radeke HH; Resch K. Molekulare Aspekte der Chronischen Entzündung. In: Handbuch der Molekularen Medizin - Band 4: Immunsystem und Infektiologie. Ganten/Ruckpaul (Hrsg.), Springer Verlag Heidelberg, 1999, pp 157-197.
32. Gessner JE; Uciechowski P; Mägert HJ; Schmidt RE; Resch K; Radeke HH. IFN-gamma induced expression of the CD16TM-receptor complex on intrinsic human glomerular mesangial cells. In: Cytokines in Hematology, Oncology, and Immunology. Eds. Freund M; Link H; Schmidt RE; Welte K; published by Springer Verlag, Berlin, 1994
31. Floege J; Radeke HR; Johnson RJ. Glomerular cells in vitro versus the glomerulus in vivo. Kidney International, 1994, 45:360-8.
30. Radeke HH; Resch
K. Schwerpunkt Immunologie: Immunpharmakologie.
Teil 1. mta - Fachzeitschrift; published
by Umschau Verlag Breidenstein GmBH, Frankfurt, 1993, 8:162-7.
29. Radeke HH; Resch K. Schwerpunkt
Immunologie: Immunpharmakologie. Teil 2. mta
- Fachzeitschrift; published by Umschau Verlag Breidenstein GmBH, Frankfurt,
1993, 8:282-91.
28. Radeke HH; Resch K. The inflammatory function of renal glomerular mesangial cells and their interaction with the cellular immune system. Clinical Investigator (Klinische Wochenschrift), 1992, 70:825-42.
______________________________________________________________________________________________________________
Selected Abstracts (2003-1995)
27. Radeke H.H., Mühl H., Spiegler S., Scheuermann E.H., Hansen C., Geiger H., Hauser I.A. Early non-invasive prediction of renal allograft rejection by interferon-gamma dependent chemokines and differentiation from other causes of graft dysfunction. 36th Ann. Meeting of the ASN San Diego, Journal of the American Society of Nephrology, [SU-FC300], 200326. Radeke H.H., von Wenckstern H., Stoidtner K., Schraut C., Kleuser B. Overlapping signalling pathways of S1P1 and S1P3 and TGFß receptors in murine dendritic cells. World Congress of Nephrology, 8.-12.06. 2003, Berlin, Nephrology Dialysis Transplantation, 18(4):563(W47), 2003
25. Frohme M., Klopp J., Schwarz M., Beissbarth T., Hoheisel J., Radeke H.H. Development of membrane and glass cDNA arrays for the analysis of genes involved in renal inflammatory migration. Naunyn-Schmiedeberg's Archives of Pharmacology, 367(1):R122(476), 2003
24. Stoidtner K.,Herrero-San Juan M., Radeke H.H. Prostaglandins differentially regulate interleukin-12/23 subunit (p40 and p35/p19) expression in murine dendritic cells. Naunyn-Schmiedeberg's Archives of Pharmacology, 367(1):R82(313), 2003
23. Radeke HH, Janssen-Graalfs I., Sowa E.N., Chouchakova N., Skokowa
J., Löscher F., Schmidt R.E., Heeringa P., Gessner J.E. Functional consequences
of a differential type II and III Fc receptor expression in mouse glomerular
mesangial cells and in the induction of anti-GBM nephritis. Journal of the American
Society of Nephrology 13:54A (SU-FC262), 2002
22. Marchand P; Resch K; Radeke HH. Inhibition of MCP-1 gene expression by triple helix-forming oligonucleotides. Naunyn-Schmiedeberg's Archives of Pharmacology. 1999, 359:334.
21. Wahl M; Resch K; Radeke HH. Immuno- and bioactive properties of native and N-terminal deleted MCP-1 generated in an eucaryotic pichia expression system. Naunyn-Schmiedeberg's Archives of Pharmacology. 1999, 359:333.
20. Gessner JE; Fossati L; Janssen-Gralfs I; Sowa E; Verbeek JS; Radeke HH; Schmidt RE; Izui S. Murine autoimmune glomerulonephritis does not require FcgRIII (CD16) for disease development. Immunobiology, 1998, 199:657.
19. Radeke HH; Lehmann PV; Karulin A; Schumm G; Emancipator SN; Tschernig T; Resch K; Tary-Lehmann M. CD4+ T cells recognizing specific antigen deposited in glomeruli cause glomerulonephritis-like kidney injury. Immunobiology, 1998, 199:499.
18. Sowa E; Gessner JE; Schwarz M; Wahl M; Janßen-Gralfs I; Radeke HH. Regulation and relative contribution of Fcg receptors, CD16, CD32 and CD64, to the activation of murine glomerular mesangial cells by immune complexes. Kidney & Blood Pressure Research, 1998, 21:149.
17. Ostendorf T; Janssen U; Burg M; Radeke HH; Green L; Janjic B; Floege J. A novel approach to specific growth factor inhibition in vivo: Antagonism of PDGF in glomerulonephritis by aptamers. Experimental Nephrology, 1998, 6:154.
16. Schwarz M; Wahl M; Marchand P; Resch K; Radeke HH. In the presence of T helper cell-derived interferon-g human glomerular mesangial cells migrate towards a MCP-1 gradient, release the autocrine growth factor FGF-2 and more MCP-1. Experimental Nephrology, 1998, 6:166.
15. Marchand P; Kaever V; von der Ohe J; Resch K; Radeke HH. Determination of the effect of immunosuppressants on T cell cytokine production at the single-cell level. Naunyn-Schmiedeberg's Archives of Pharmacology, 1998, 357:320.
14. Schwarz M; Wahl M; Marchand P; Resch K; Radeke HH. Chemokines centrally involved in immune cell attraction in nephritis are potent activators and chemoattractants of glomerular mesangial cells. Naunyn-Schmiedeberg's Archives of Pharmacology, 1998, 357:321.
13. Schwarz M; Uciechowski P; Resch K; Radeke HH. Human glomerular mesangial cells respond to chemokines via inducible chemokine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology, 1997, 355:303.
12. Neumann D; Schwarz M; Radeke HH; Resch K. ICE-like proteases are involved in interleukin-1ß induced prostaglandin-2 release in glomerular mesangial cells. Naunyn-Schmiedeberg's Archives of Pharmacology, 1997, 355:R20.
11. Uciechowski P; Schwarz M; Gessner JE; Schmidt RE; Resch K; Radeke HH. Functional expression of the high affinity Fc receptor I for IgG (CD64) by human glomerular mesangial cells. Immunobiology, 1996, 196:23.
10. Uciechowski P; Schwarz M; Resch K; Radeke HH. Different regulation of chemokine expression by human intrinsic glomerular mesangial cells. Kidney International, 1996, 50:1805.
9. Radeke HH; Lehmann PV; Robinson J; Karulin A; Emancipator SN; Tary-Lehmann M. Role of T lymphocytes in glomerulonephritis. Kidney International, 1996, 50:1787.
8. Turck J; Radeke HH; Lovett DH. The N-terminal propiece of interleukin 1a is a pro-apoptotic factor. Journal of the American Society of Nephrology, 1995, 6:779.
______________________________________________________________________________________________________________
Parathyroid Hormone / Calcium Metabolism (1983-1990)
7. Koch T; Lehnhardt E; Bottinger H; Pfeuffer T; Palm D; Fischer B; Radeke HH; Hesch RD. Sensorineural hearing loss owing to deficient G proteins in patients with pseudohypoparathyroidism: results of a multicentre study. European Journal of Clinical Investigation, 1990, 20:416-21.
6. Radeke HH; Aufm'kolk B; Jüppner H; Krohn H-P; Keck E; Hesch RD. Multiple pre- and postreceptor defects in pseudohypoparathyroidism (A multicenter study with twenty four patients). Journal of Clinical Endocrinology and Metabolism, 1986, 62:393-402 (PDF)
5. Schettler T; Aufm'kolk B; Atkinson MJ; Radeke HH; Enters C; Hesch RD. Analysis of immunoreactive and biological active human parathyroid hormone-peptides by high-performance-liquid-chromatography. Acta Endocrinologica, 1984, 107:60-9.
4. Niepel B; Radeke HH; Atkinson
MJ; Jüppner H; Hesch RD.
A homologous biological probe for parathyroid hormone in
human serum.
Journal of Immunoassay, 1983, 4:21-47.
______________________________________________________________________________________________________________
Reviews / Invited Contributions / Book Chapters
3. Radeke HH: Angeborene und erworbene Rezeptordefekte.
In: Innere Medizin der Gegenwart, Eds.: W.
Gerok, F. Hartmann, H.-P. Schuster; Vol. 4: Endokrinologie,
Ed.: R.-D. Hesch, Part A: Grundlagen; published by Urban & Schwarzenberg,
München; Wien; Baltimore, 1989, Chap. 26:598-611.
2. Radeke HH: Gestörte Hormon-Rezeptor-Interaktion. In:
Innere Medizin der Gegenwart, Eds.: W. Gerok, F.
Hartmann, H.-P. Schuster; Vol. 4: Endokrinologie, Ed.:
R.-D. Hesch, Part A: Grundlagen;
published by Urban & Schwarzenberg, München; Wien;
Baltimore, 1989, Chap. 36, 761-70.
1. Radeke HH: Pseudohypoparathyreoidismus.
In: Innere Medizin der Gegenwart, Eds.: W. Gerok, F.
Hartmann, H.-P. Schuster; Vol. 5: Endokrinologie, Ed.:
R.-D. Hesch, Part B: Krankheitsbilder;
published by Urban & Schwarzenberg, München; Wien;
Baltimore, 1989, Chap. 46.3:978-87.